Matches 1 - 50 out of 278 1 2 3 4 5 6 >

AcclaimIP-ad

Match Document Document Title
US20110110882 CROSS-LINKED COMPOSITIONS  
Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and...
US20150150781 Dental Care Product with Two-part Formulations and Utility Thereof  
A dental care product comprises an orally acceptable carrier or excipient, and a bacterial resistance copolymer, which comprises a zwitterionic block and a charged anchoring block, wherein the...
US20130216599 ANTIMICROBIAL PARYLENE COATINGS AND METHODS OF DEPOSITING SAME  
Antimicrobial parylene coatings and methods for their vapor-phase deposition.
US20130011456 ANTIMICROBIAL PARYLENE COATINGS AND METHODS OF DEPOSITING SAME  
Antimicrobial parylene coatings and methods for their vapor-phase deposition.
US20120003176 HYDROGEL-FORMING COMPOSITION COMPRISING NATURAL AND SYNTHETIC SEGMENTS  
A hydrogel composition is formed from a natural polymer derivative having a plurality of cross-linkable units depending therefrom, and a synthetic polymer derivative having a plurality of...
US20060120993 Treatment of lesions of the soft tissues  
The invented remedy allows cleaning up the area from necrotic tissues and facilitating reduced perifocal oedema and infiltration as well as lessening pain syndrome during suppurative inflammation...
US20100330143 MODIFIED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF  
Described herein are composites produced by reacting a first thiolated macromolecule with at least one compound having at least one thiol-reactive electrophilic functional group. The methods...
US20110014292 METHOD OF PROPHYLAXIS AND AGENTS FOR USE THEREIN  
The present invention relates generally to a method of prophylactically or therapeutically treating antigen-induced airway tissue inflammation and agents for use therein. More particularly, the...
US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue  
The present invention encompasses methods and compositions for generating a biomimetic proteoglycan. The invention includes methods of treating a disease, disorder, or condition of soft tissue...
US20130189219 N-TERMINALLY CHEMICALLY MODIFIED PROTEIN COMPOSITIONS AND METHODS  
Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof,...
US20110097376 RADIOPAQUE INJECTABLE NUCLEUS HYDROGEL COMPOSITIONS  
A composition suitable for use as replacement material for all or part of a disc nucleus during percutaneous injection, the composition comprising: an injectable, curable, cross-linkable,...
US20110171167 Isocyanate-Based Compositions and Their Use  
The present disclosure describes a method and a kit for bulking, augmenting or occluding a tissue comprising administering a sufficient amount of a composition containing a biocompatible,...
US20150056157 VASCULAR DELIVERY SYSTEMS  
The site-specific expression of selectins on endothelial cells of blood vessels during angiogenesis provides an opportunity to target anti-cancer drugs to the vascular endothelium to extend the...
US20140056841 Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms  
Compositions are provided for promoting healing of tissue of a vertebrate organism. The compositions can be for internal administration of a therapeutically effective amount of pharmacologically...
US20150079020 INJECTABLE HYDROGELS  
The present disclosure generally relates to injectable compositions. More particularly, the present disclosure relates to injectable, thermogelling hydrogels and associated methods. In one...
US20130177523 GOLD PARTICLES AND METHODS OF MAKING AND USING THE SAME IN CANCER TREATMENT  
Described herein are gold particles that can be used to reduce tumor proliferation and treat cancer. In certain aspects, the gold particles can be modified in order to enhance selectivity and...
US20150071872 POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS  
The present invention relates to compositions for the treatment of cancerous tissues in warm-blooded animals containing one or two anticancer agents attached to polymeric carriers having monomer...
US20110117164 Use of Additive Sites to Control Nitric Oxide Release from Nitric Oxide Donors Contained within Polymers  
A method for increasing, prolonging, and/or controlling the release rates of nitric oxide (NO) from polymeric materials containing NO adducts. Such NO-containing polymeric materials may find use...
US20130156722 POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF  
Described herein are biodegradable drug delivery conjugates for effectively delivering bioactive agents to a subject. The drug delivery conjugates comprise a water-soluble high molecular weight...
US20150024017 COMPOSITIONS AND METHODS FOR CELL KILLING  
A solid buffer including one or more ion exchange materials, wherein said solid buffer has a volumetric buffering capacity greater than about 20 mM H+/(L·pH unit) and further wherein, when said...
US20120189571 NANOSCALE PLATINUM COMPOUNDS AND METHODS OF USE THEREOF  
The invention is directed to biocompatible conjugated polymer nanoparticles including a copolymer backbone, a plurality of sidechains covalently linked to said backbone, and a plurality of...
US20130236416 SURFACE MODIFIED COLLOIDAL PARTICLES  
The present invention generally relates to surface modified colloidal particles. The invention further relates to methods of preparing and methods of using the same.
US20140294751 Hemocompatibility Modifiers for Cross-Linked Polymeric Material  
The invention concerns methods of treating blood, blood product, or physiologic fluid to provide at least one of (i) increasing shelf life of the blood, blood product or physiologic fluid, (ii)...
US20140112881 CROSSLINKED POLYMER NANO-ASSEMBLIES AND USES THEREOF  
The invention provides a novel system of nano-assemblies and related method for delivery of therapeutic, diagnostic or imaging agent to biological sites. The compositions and methods of the...
US20110200655 Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic  
A medical product is provided that is selected from at least one of, nasal cannulas, oxygen masks, wound dressings, bandages, band aids, catheters, endotrachial tubes, condoms, surgical and other...
US20120269897 POLY(TETRAFLUOROETHYLENE) POLYMER WITH NITRIC OXIDE DONATING SURFACE  
Described herein are nitric oxide (NO)-donating poly(tetrafluoroethylene) (PTFE) polymers and polymer surfaces and methods of making and using the same. The NO-donating PTFE polymers can be used...
US20120107264 NUCLEIC ACID DELIVERY COMPOUNDS  
Polymers including two or more different recurring units are disclosed herein. Also disclosed herein are methods of using such polymers to deliver nucleic acids to a cell.
US20060013799 Multimeric VLA-4 antagonists comprising polymer moieties  
Disclosed are conjugates which bind VLA-4. Certain of these conjugates also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such conjugates are useful in the...
US20130011363 CATIONIC BETAINE PRECURSORS TO ZWITTERIONIC BETAINES HAVING CONTROLLED BIOLOGICAL PROPERTIES  
Cationic polymers hydrolyzable to zwitterionic polymers, monomers for making the cationic polymers, surfaces that include the polymers, therapeutic agent delivery systems that include the cationic...
US20130115165 Water-Dispersible Oral, Parenteral, and Topical Formulations for Poorly Water Soluble Drugs Using Smart Polymeric  
Polymeric nanoparticles with a hydrophobic core and a hydrophilic shell are formed from: 1) N-isopropylacrylamide (NIPAAM), at a molar ratio of about 50% to about 90%, and preferably 60% for...
US20140271891 PHENYLEPHRINE RESINATE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS  
Phenylephrine particles suitable for solid, semi solid or liquid dosage forms are disclosed.
US20050271590 Treatment of myopia  
The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment and/or...
US20050175704 Polyacrylamide hydrogel as a soft tissue filler endoprosthesis  
A hydrogel is obtained by combining acrylamide and methylene bis-acrylamide, radical initiation and washing with pyrogen-free water or saline solution to give less than 3.5% by weight...
US20070128152 Biocompatible tissue sealants and adhesives  
The disclosure relates to compositions for medical/surgical synthetic adhesives and sealants. Adhesive compositions include a functionalized triol and functionalized diol, while sealant...
US20070048358 Antimicrobial substrates  
A synergistic antimicrobial composition containing at least two kinds of antimicrobial agents, including poly-hexamethylene biguanide (PHMB), stably associated to a material substrate is...
US20060280720 Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant  
A novel macromer or mixture thereof is described herein, comprising benzoyl isocyanate terminal moieties and at least two residues of a water-soluble polymer having a molecular weight ranging from...
US20050025741 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis  
The invention relates generally to polymers and copolymers comprising N-vinylamide-type monomers, their preparation, and compositions, such as electrophoresis separation media, containing the...
US20070274945 High molecular weight chelation structure  
A chelation structure and method of forming and using the chelation structure. The chelation structure has a backbone that includes a linear sequence of monomeric backbone units, at least one...
US20150030664 BLOOD COAGULATION INDUCING POLYMER HYDROGEL  
The present application is drawn to a synthetic, polymer hydrogel-based material, which is able to actively induce the body's natural hemostatic coagulation process in blood or acellular plasma....
US20120065614 POLYIONIC TRANSITIONAL METAL PHOSPHORESCENT COMPLEX/POLYMER HYBRID SYSTEMS FOR BIOIMAGING AND SENSING APPLICATIONS  
A new technique to stabilize transition metal phosphors in a wide variety of stimuli-sensitive polymers and gels is disclosed herein. Other than stabilization in stimuli sensitive/biocompatible...
US20050042196 Antimicrobial phenol containing cyanoacrylate compositions  
Disclosed are methods and formulations for the treatment or prevention of infections on mammalian tissues such as skin. Specifically, the methods of this invention involve the in situ formation of...
US20130287726 COMPOSITIONS COMPRISING SEMAPHORINS FOR THE TREATMENT OF ANGIOGENESIS RELATED DISEASES AND METHODS OF SELECTION THEREOF  
A method of selecting a semaphorin for treating cancer in a subject is disclosed. The method comprises determining an expression of a semaphorin receptor on tumor cells of a tumor sample of the...
US20050008613 Antimicrobial quaternary ammonium organosilane coatings  
The present invention provides novel solid phase carriers coated with a quaternary ammonium organosilane coating for use in reducing or eliminating the viable number of microorganisms in a liquid....
US20060002890 Hydrogel formulations  
A polymeric prodrug composition including a hydrogel, a biologically active moiety and a reversible prodrug linker. The prodrug linker covalently links the hydrogel and the biologically active...
US20150224069 METHOD OF TREATMENT OF PERIODONTUM AND DAMAGED ORAL TISSUE BY ADMINISTERING ORAL COMPOSITIONS COMPRISING SUPRAMOLECULAR COMPLEXES OF POLYANIONIC POLYMERS AND SPERMIDINE  
The invention is related to a method for the treatment, maintenance or repair of periodontum and oral tissues comprising administering oral compositions containing supramolecular complexes formed...
US20060282035 Cyanoacrylate adhesive applicator swab  
A swab applicator for containing and dispensing cyanoacrylate adhesives is disclosed. The device comprises a tube applicator with a valve to contain the cyanoacrylate until use. The valve can be a...
US20130243720 Iron(II)-Containing A Treatments for Hyperphosphatemia  
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable...
US20060210528 Therapy for tropical diseases  
Disclosed are methods and formulations for the treatment of topical conditions on mammalian tissues such as skin and mucous tissues mediated at least -in part by viral, bacterial or fungal...
US20050036981 USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY  
This invention relates to methods of modifying pyridoxal 5′ phosphate (PLP) dependent enzymes to extend the serum half-life of the enzyme, extend the in vivo period of methionine depletion in a...
US20060018847 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations  
The invention is an active ingredient combination comprising polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and a cosmetic or dermatological formulation...
Matches 1 - 50 out of 278 1 2 3 4 5 6 >